KVP Capital Advisors, LP
SAN FRANCISCO, CA · CIK 1858198 · 13F filing filed 2026-08-13
SEC-registered investment adviser since 2026 · limited partnership
- Assets managed$220.9m
- Staff3 · 2 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds2 (1 hedge) · $220.9m gross assets
- Websitekearnyvp.com
- Form ADV · 2026-06-29SEC adviser record
- Kindhedge funds, private equity
- Others nearbySan Francisco, CA
As an employer
- Offices in1 country
- Private fundshedge 2, private equity 2
$136.2m
reported value
+1.7% vs Q1 2026
35positions
57.4%in top 10
6 new
2 added
2 reduced
3 sold out
vs Q1 2026
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| PRAXIS PRECISION MEDICINES I PRAX | $14.4m10.54% | Unchanged |
| AADI BIOSCIENCE INC WHWK | $9.9m7.28% | Unchanged |
| ERASCA INC ERAS | $8.3m6.12% | Added +115.0k |
| TREVI THERAPEUTICS INC TRVI | $7.7m5.67% | Unchanged |
| SUTRO BIOPHARMA INC STRO | $7.5m5.52% | Unchanged |
| TANGO THERAPEUTICS INC TNGX | $7.2m5.28% | Unchanged |
| MBX BIOSCIENCES INC MBX | $6.7m4.92% | Unchanged |
| PROTAGONIST THERAPEUTICS INC PTGX | $6.5m4.77% | Unchanged |
| EDGEWISE THERAPEUTICS INC EWTX | $5.4m3.97% | Unchanged |
| TANDEM DIABETES CARE INC TNDM | $4.5m3.33% | New |
| DISC MEDICINE INC IRON | $4.3m3.13% | Unchanged |
| SAVARA INC SVRA | $3.7m2.74% | Unchanged |
| ARRIVENT BIOPHARMA INC AVBP | $3.5m2.60% | New |
| INSMED INC INSM | $3.0m2.23% | Unchanged |
| ACHIEVE LIFE SCIENCES INC ACHV | $3.0m2.22% | Unchanged |
| IDEAYA BIOSCIENCES INC IDYA | $3.0m2.18% | Unchanged |
| OCULAR THERAPEUTIX INC OCUL | $2.9m2.16% | Unchanged |
| AXSOME THERAPEUTICS INC AXSM | $2.9m2.16% | Reduced -24.2k |
| DESIGN THERAPEUTICS INC DSGN | $2.7m1.96% | New |
| UNITED THERAPEUTICS CORP DEL UTHR | $2.6m1.89% | Unchanged |
| SCHOLAR ROCK HLDG CORP SRRK | $2.5m1.82% | Unchanged |
| IMMIX BIOPHARMA INC IMMX | $2.4m1.74% | Unchanged |
| VIRIDIAN THERAPEUTICS INC VRDN | $2.3m1.69% | Unchanged |
| MINERALYS THERAPEUTICS INC MLYS | $2.3m1.67% | New |
| BRIGHT MINDS BIOSCIENCES INC DRUG | $2.2m1.64% | Unchanged |
| TRAVERE THERAPEUTICS INC TVTX | $2.2m1.63% | Reduced -52.0k |
| ZURA BIO LTD ZURA | $2.2m1.62% | Unchanged |
| ARTIVA BIOTHERAPEUTICS INC ARTV | $1.9m1.42% | New |
| NEKTAR THERAPEUTICS NKTR | $1.9m1.38% | Unchanged |
| COMPASS THERAPEUTICS INC CMPX | $1.7m1.24% | Added +271.0k |
| CABALETTA BIO INC CABA | $1.6m1.15% | Unchanged |
| VERA THERAPEUTICS INC VERA | $1.4m1.03% | Unchanged |
| EVOLUS INC EOLS | $1.0m0.76% | New |
| CELCUITY INC CELC | $418.5k0.31% | Unchanged |
| VYNE THERAPEUTICS INC COM | $325.7k0.24% | Unchanged |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| TERNS PHARMACEUTICALS INC | $23.2m440.0k shares |
| REVOLUTION MEDICINES INC RVMD | $3.9m40.2k shares |
| SOLENO THERAPEUTICS INC SLNO | $2.0m59.7k shares |